journal
Journals Therapeutic Advances in Vaccin...

Therapeutic Advances in Vaccines and Immunotherapy

https://read.qxmd.com/read/38726045/exploring-social-media-influences-on-vaccine-decision-making-in-parents-a-netnography
#1
JOURNAL ARTICLE
Susan E Smith, Nina Sivertsen, Lauren Lines, Anita De Bellis
BACKGROUND: Immunization is one of the most significant health initiatives of recent times. Despite this, vaccine hesitancy is increasing and was listed as one of the top 10 threats to global health by the World Health Organization in 2019. A major factor associated with vaccine hesitancy is thought to be the viral spread of misinformation by a small but active anti-vaccination movement. OBJECTIVES: The purpose of this study was to explore the influences of social media on vaccine decision-making in parents...
2024: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/38322819/adjuvants-in-covid-19-vaccines-innocent-bystanders-or-culpable-abettors-for-stirring-up-covid-heart-syndrome
#2
REVIEW
Sri Harsha Kanuri, Prapthi Jayesh Sirrkay
COVID-19 infection is a multi-system clinical disorder that was associated with increased morbidity and mortality. Even though antiviral therapies such as Remdesvir offered modest efficacy in reducing the mortality and morbidity, they were not efficacious in reducing the risk of future infections. So, FDA approved COVID-19 vaccines which are widely administered in the general population worldwide. These COVID-19 vaccines offered a safety net against future infections and re-infections. Most of these vaccines contain inactivated virus or spike protein mRNA that are primarily responsible for inducing innate and adaptive immunity...
2024: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/38178960/lessons-learned-from-a-cluster-of-immunization-errors-in-newborns
#3
JOURNAL ARTICLE
Loubna Alj, Amina Tebaa, Ismail Talibi, Sofia Moubarik, Mohammed Benazzouz, Rachida Soulaymani Bencheikh
BACKGROUND: Vaccines are safe and effective, but adverse reactions can occur. Immunization errors (IEs) are one of the types of adverse events following immunization. The Moroccan Pharmacovigilance Centre (MPC) received a cluster of IEs from a maternity university hospital (MUH) regarding six newborns who were inadvertently administered rocuronium instead of hepatitis B (HepB) vaccine. The newborns experienced respiratory distress and one had a fatal outcome. OBJECTIVES: The study aimed to describe the investigation findings, the underlying causes, and contributing factors of the IEs cluster, and proposed risk minimization actions...
2024: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/38107389/addressing-disparities-in-funding-for-robust-cancer-research
#4
JOURNAL ARTICLE
Dalmacito A Cordero
No abstract text is available yet for this article.
2023: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/38090642/stagnation-or-safety-reassessment-of-the-human-papillomavirus-vaccination-dosing-regimen-in-japan
#5
JOURNAL ARTICLE
Mira Namba, Yudai Kaneda, Miho Iida
No abstract text is available yet for this article.
2023: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/38077267/efficacy-of-oral-mefenamic-acid-versus-paracetamol-as-a-prophylactic-analgesic-for-needle-pain-in-children-receiving-vaccination-a-three-arm-parallel-triple-blind-placebo-controlled-map-vac-randomized-controlled-trial
#6
JOURNAL ARTICLE
Rachna Pasi, Thirunavukkarasu Arun Babu, Vinoth Kumar Kallidoss
BACKGROUND: Needle pain due to routine vaccination is an important factor contributing to low vaccine adherence and immunization coverage. Prophylactic oral analgesics can address this important issue of needle pain related to vaccination. Paracetamol and mefenamic acid are commonly used nonsteroidal anti-inflammatory drugs for pain relief, but there is little published literature on whether the same can be used for needle pain related to vaccination. OBJECTIVES: This study was planned to compare the efficacy of oral mefenamic acid and paracetamol over placebo as a prophylactic analgesic during vaccination and prophylactic antipyretic during the post-vaccination period...
2023: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/38020960/flu-vaccination-in-the-philippines-challenges-and-interventions
#7
JOURNAL ARTICLE
Dalmacito A Cordero
No abstract text is available yet for this article.
2023: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/38020959/designing-an-inclusive-immunization-schedule-for-children-and-adults-in-india
#8
JOURNAL ARTICLE
Farah Niazi, Karuna Nidhi Kaur, Shazina Saeed, Mohd Shannawaz
No abstract text is available yet for this article.
2023: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/37954638/covid-19-vaccine-immune-response-and-plasma-cell-dyscrasia
#9
JOURNAL ARTICLE
Amnuay Kleebayoon, Viroj Wiwanitkit
No abstract text is available yet for this article.
2023: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/37886714/cancer-vaccine-strategies-for-the-treatment-of-diffusely-infiltrating-gliomas
#10
REVIEW
Alexander Jucht, Sydney Dumont, Channing Pooley, Luis Nicolas Gonzalez Castro
Diffusely infiltrating gliomas - including glioblastoma (GBM), isocitrate dehydrogenase (IDH) mutant gliomas, and histone 3 (H3) altered gliomas - are primary brain tumors with an invariably fatal outcome. Despite advances in the understanding of their biology, standard, targeted and immune checkpoint inhibitor immunotherapies have proven ineffective in arresting their inexorable progression and associated morbidity and mortality. Recognizing the unique aspects of the immunogenicity of cancer cells, the last decade has seen the development and evaluation of vaccine-based therapies for the treatment of solid tumors, including gliomas...
2023: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/37719802/significant-improvement-of-systemic-lupus-erythematosus-manifestation-in-children-after-autologous-dendritic-cell-transfer-a-case-report-and-review-of-literature
#11
Jonny, Terawan Agus Putranto, Yenny Purnama, Roedi Djatmiko, Martina Lily Yana, Enda Cindylosa Sitepu, Raoulian Irfon
Dendritic cells (DC) are postulated to play a role in autoimmune diseases such as Systemic Lupus Erythematosus (SLE). We reported a 13-year-old female SLE patient who presents with chronic arthritis accompanied by persistent fever, dyspnea, sleep disturbance, headache, stomatitis, rash, and muscle weakness. The supporting examinations showed abnormal blood cell counts, positive antinuclear antibody profile, serositis, and neuropathy. Immunosuppressants failed to improve the condition. DC-based vaccine derived from autologous peripheral blood which was introduced with SARS-CoV-2 protein was given to this patient...
2023: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/37662491/immune-checkpoints-and-cancer-immunotherapies-insights-into-newly-potential-receptors-and-ligands
#12
REVIEW
Ali N Kamali, José M Bautista, Michael Eisenhut, Haleh Hamedifar
Checkpoint markers and immune checkpoint inhibitors have been increasingly identified and developed as potential immunotherapeutic targets in various human cancers. Despite valuable efforts to discover novel immune checkpoints and their ligands, the precise roles of their therapeutic functions, as well as the broad identification of their counterpart receptors, remain to be addressed. In this context, it has been suggested that various putative checkpoint receptors can be induced upon activation. In the tumor microenvironment, T cells, as crucial immune response against malignant diseases as well as other immune central effector cells, such as natural killer cells, are regulated via co-stimulatory or co-inhibitory signals from immune or tumor cells...
2023: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/37645011/covid-19-vaccine-immune-response-in-patients-with-plasma-cell-dyscrasia-a-systematic-review
#13
REVIEW
Unaiza Faizan, Lakshmi G Nair, Maroun Bou Zerdan, Majid Jaberi-Douraki, Faiz Anwer, Shahzad Raza
BACKGROUND: Patients with plasma cell dyscrasia are at a higher risk of developing a severe Coronavirus-2019 (COVID-19) infection. Here we present a systematic review of clinical studies focusing on the immune response to the COVID-19 vaccination in patients with plasma cell dyscrasia. OBJECTIVES: This study aims to evaluate the immune response to COVID-19 vaccines in patients with plasma cell dyscrasia and to utilize the results to improve day-to-day practice. DESIGN: Systematic Review...
2023: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/37641637/active-surveillance-of-adverse-events-following-covid-19-vaccines-in-a-tertiary-care-hospital
#14
JOURNAL ARTICLE
Naveena Mary Cherian, Dravya Anna Durai, Muhammed Jaisel, Divyansh Sharma, Juny Sebastian, Chetak Kadabasal Basavaraja, Merrin Mathew
BACKGROUND: Vaccination is a safe and effective way to prevent disease and save lives, but it may also produce some undesirable adverse events (AEs)which may affect healthy individuals. Therefore, the monitoring of AE following immunization (AEFIs) is necessary. The objective of this study was to assess the AEs following COVID-19 vaccinations in a tertiary care hospital. METHODOLOGY: The study was conducted as active vaccine safety surveillance for a period of 6 months among the COVID-19 vaccine beneficiaries of the study site...
2023: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/37377465/covid-19-vaccine-acceptance-and-its-determinants-among-residents-of-ambo-town-west-shewa-oromia-region-ethiopia-cross-sectional-survey
#15
JOURNAL ARTICLE
Tamirat Bekele Beressa, Milkessa Tafa, Gudeta Duga Geresu, Amente Jorise Bacha, Diriba Alemayehu Gadisa
BACKGROUND: Vaccines against COVID-19 are critical for preventing and managing COVID-19 because immunization is one of the most active and cost-effective health strategies for infectious disease prevention. Knowing the community's willingness and factors affecting COVID-19 vaccine acceptance will support the design of effective promotion strategies. Therefore, this study was aimed at assessing COVID-19 vaccine acceptance and its determinants among the Ambo Town community. METHOD: A community-based, cross-sectional study was conducted using structured questionnaires from 1 to 28 February 2022...
2023: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/37362156/clinico-epidemiological-profile-and-outcome-of-infected-health-care-workers-during-the-three-consecutive-waves-of-covid-19-pandemic-a-longitudinal-cohort-study
#16
JOURNAL ARTICLE
Merrin Mathew, Juny Sebastian, Narayanappa Doddaiah, Anmaria Thomas, Sinchana Narayanappa
BACKGROUND: Health care workers are considered as high-risk population, who deal with many unknown, undiagnosed, and subclinical infectious diseases in their daily life. Currently, the COVID-19 pandemic posed as an add-on burden for these frontline workers in all aspects. Although, many adverse physical and mental effects of pandemic among health care workers (HCWs) were discussed worldwide, a long-term study for delayed complications needed to be explored. AIM: The study evaluates and compares three waves of the pandemic in various aspects such as the incidence, prevalence, severity, risk factors, and variations in the pattern of COVID-19 infection, impact of vaccination, and post-infection complications among the HCWs...
2023: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/37362155/covid-19-after-rituximab-therapy-in-csle-patients
#17
Meghan Corrigan Nelson, Cynthia K Manos, Elaine Flanagan, Sampath Prahalad
Childhood-onset systemic lupus erythematosus (cSLE) is an autoimmune disease associated with significant morbidity and mortality. Rituximab is a B-cell depleting therapy utilized in the treatment of SLE. In adults, rituximab has been associated with increased risk of adverse outcomes in patients who develop coronavirus disease 2019 (COVID-19). We aimed to assess the impact of prior rituximab treatment on clinical outcomes from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in children with SLE...
2023: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/37261278/leveraging-identity-and-access-management-technology-to-accelerate-emergency-covid-19-vaccine-delivery
#18
George A Gellert
COVID-19-related vaccine demand and delivery volume challenged delivery organizations as few crises have. Imperatives to ensure security of patient information, defend against cybersecurity threats, and accurately identify/authenticate clinician identity for patients remained unchanged. Deployment of identity access and management (IAM) and single sign-on (SSO) can accelerate operationalization of a vaccine delivery center when urgently needed in a crisis. Innovative application of existing IAM/SSO technology, combined with an identity governance solution, greatly accelerated vaccine delivery...
2023: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/37124959/immunogenicity-and-safety-of-vaccination-in-children-with-paediatric-rheumatic-diseases-a-scoping-review
#19
REVIEW
Jacqueline Cunninghame, Sophie Wen, Mitchell Dufficy, Amanda Ullman, Mari Takashima, Megan Cann, Rebecca Doyle
Children with paediatric rheumatic diseases (PRDs) are at increased risk of vaccine-preventable disease. Safe and effective vaccination is central to preventive care in PRD patients; however, uncertainty surrounding immunogenicity and safety has contributed to suboptimal vaccination. The aim of this study was to evaluate treatment effect on immunogenicity to vaccination in PRD patients and assess vaccine safety, specifically adverse events following immunisation (AEFI) and disease flare. Scoping review. In this scoping review, a systematic search of PubMed, CINAHL and Embase databases was conducted from 2014 to 23 August 2022 to identify observational studies evaluating the immunogenicity and safety of commonly used vaccinations in PRD patients...
2023: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/36778098/socioeconomic-and-demographic-characteristics-influencing-the-hesitancy-and-refusal-of-covid-19-vaccine-in-ghana
#20
JOURNAL ARTICLE
Agyemang Kwasi Sampene, Cai Li, Fredrick Oteng Agyeman, Robert Brenya
BACKGROUND: Ghana was the first country to receive the coronavirus vaccination in West Africa from AstraZeneca or Oxford. Ghana plans to vaccinate 20 million out of the 32 million population and provide the necessary doses utilizing multilateral and bilateral agreements. As Ghana begins vaccinating its citizens, there is some skepticism about administering the coronavirus vaccine (CVV). This research aimed to analyze the socioeconomic and demographic characteristics influencing vaccine hesitancy (VH) and refusal among Ghanaians...
2023: Therapeutic Advances in Vaccines and Immunotherapy
journal
journal
56948
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.